21st October 2019 – Global Peptide
Therapeutics Market is predicted to reach USD 48.04 billion by 2025
owing to rise in demand for efficient & speedy treatment of cancer and
other lifestyle-related disorders. Peptides are the naturally occurring
biological molecules that are used in drugs to improve the patient’s medical
condition. They are highly safe and effective due to which they are widely
accepted by physicians and patients for treating several ailments.
In the medical practice, they are ideal
for diabetes, infectious diseases, several type of cancers, cardiovascular and
other medical conditions. Peptides are highly modifiable and versatile in
comparison to other drugs, which make them highly profitable to sponsors. Due
to their feature of versatility, they are used in multiple medical conditions
that leads to higher penetration of peptide therapeutics industry. Apart from
therapeutics effects, the market is also gaining attraction due to
comparatively easy marketing approval and familiarity.
Along with the growing prevalence of
cardiovascular disorders and cancers, the increasing research & development
activities and rich peptide therapeutics pipeline are predicted to support the
growth of the market in near future. The patent expiration of various peptide
drugs in future is expected to create ample opportunities for the market
contributing to its growth at a significant rate.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/peptide-therapeutics-market/request-sample
Peptide therapeutics have application in
CNS (Central Nervous System) disorders and respiratory disorders due to
features like safe, efficiency and versatility. Advanced research &
development facilities and new peptide developments by pharma companies are
driving the demand for reasonably priced peptide therapeutics.
Nevertheless, the large scale production
of peptide with increasing complexities of peptides is a major challenge for
peptide therapeutics market. The development of multifunctional peptides and
rise in number of collaboration for the progress of peptide conjugates are
currently ruling the market.
Latest advances in peptide synthesis
technology is projected to be the key driver for the growth of peptide
therapeutics industry. From among the different methods of peptide synthesis,
enzymatic and chemical synthesis are important. This technology has integrated
structure-activity relationships (SARs) and analog generation to increase bioavailability,
increase safety & efficacy of drugs, impart protease resistance, reduce
adverse effects, and develop formulations.
The other driving factor of the market
is the shift towards unexploited market. The market is witnessing several
vendors focusing on developing economies due to presence of large population
groups and clinical trial subjects. Factors like presence of lenient regulatory
guidelines, skilled labor, limited market competition, and low manufacturing
costs will encourage vendors to shift their manufacturing processes to the
developing economies.
Peptide therapeutics market is
categorized on the basis of application, technology, route of administration,
molecule type, API peptide type, and geography. On the basis of application,
the market is divided into Cancer, Metabolic, CVD, Respiratory, GIT,
Anti-infective, Dermatology, CNS, Renal, etc. In terms of route of
administration, the market is segmented as Parenteral, Oral, etc.
On the basis of type, peptide
therapeutics industry is divided into Innovative and Generic. On the basis of
technology, the market is classified into Liquid Phase, Solid Phase, and Hybrid
Phase. Type of Molecule is classified into Vasopressin, Somatostatin,
Calcitonin, Immunopeptide, Natriuretic, and others. On the basis of API Peptide
Type, the market is divided into In-house, and CMO (contract manufacturing
organization).
Geographically, peptide therapeutics
market is segmented as North America, Latin America, Europe, Asia Pacific, and
Middle East & Africa. North America and Latin America are predicted to hold
larger share of the market owing to the rising incidences of cancer and other
life-style related disorders.
The key peptide therapeutics industry
players comprise AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Sanofi,
CordenPharma International GmbH, Teva Pharmaceutical Industries Ltd., Novartis
AG, Ipsen S.A., Lonza Group Ltd., Merck & Co. Inc., F. Hoffmann-La Roche
AG, Bachem Holding AG, PolyPeptide Group and Novo Nordisk A/S.
Get
in touch
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment